| Date Checked | 2026-06-19 22:47:06 |
|---|---|
| Graham Number | (PB)nan vs (PE)0.00 |
| Over / Under Value Percentage | 0.00% vs 0.00% |
| Dividend Yield | 0.00% |
| Dividend Date | None |
| Symbol | SANA |
| AssetType | Common Stock |
| Name | Sana Biotechnology Inc |
| Description | Sana Biotechnology, Inc., a biotechnology company, focuses on the use of modified cells as medicines. The company is headquartered in Seattle, Washington. |
| CIK | 1770121 |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | BIOTECHNOLOGY |
| Address | 188 EAST BLAINE STREET, SEATTLE, WA, UNITED STATES, 98102 |
| OfficialSite | https://www.sana.com |
| FiscalYearEnd | December |
| LatestQuarter | 2026-03-31 |
| MarketCapitalization | 784782000 |
| EBITDA | -168568992 |
| PERatio | 0 |
| PEGRatio | None |
| BookValue | 0.603 |
| DividendPerShare | None |
| EPS | -0.92 |
| RevenuePerShareTTM | 0 |
| ProfitMargin | 0 |
| OperatingMarginTTM | 0 |
| ReturnOnAssetsTTM | -0.275 |
| ReturnOnEquityTTM | -1.474 |
| RevenueTTM | 0 |
| GrossProfitTTM | 0 |
| DilutedEPSTTM | -0.92 |
| QuarterlyEarningsGrowthYOY | 0 |
| QuarterlyRevenueGrowthYOY | 0 |
| AnalystTargetPrice | 8.57 |
| AnalystRatingStrongBuy | 2 |
| AnalystRatingBuy | 6 |
| AnalystRatingHold | 1 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 0 |
| TrailingPE | - |
| ForwardPE | - |
| PriceToSalesRatioTTM | - |
| PriceToBookRatio | 6.56 |
| EVToRevenue | - |
| EVToEBITDA | -1.082 |
| Beta | 2.159 |
| 52WeekHigh | 6.55 |
| 52WeekLow | 2.41 |
| 50DayMovingAverage | 3.234 |
| 200DayMovingAverage | 3.842 |
| SharesOutstanding | 278292000 |
| SharesFloat | 169914000 |
| PercentInsiders | 6.507 |
| PercentInstitutions | 82.834 |
| ExDividendDate | None |
| dateChecked | 2026-06-19 22:47:06 |
| fresh | 1 |